SP
GMED icon

SWS Partners’s Globus Medical GMED Stock Holding History

SWS Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-128
Closed -$8.77K – 184
2024
Q2 		$8.77K Buy
+128
New +$7.65K ﹤0.01% 258

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

SWS Partners's GMED Position: Q3 2024 in Review

SWS Partners sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 128 shares — an estimated $8.77K sold.

SWS Partners first reported a position in GMED in Q2 2024 and held it in 1 quarter. The position peaked at $8.77K in Q2 2024. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • SWS Partners reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • SWS Partners sold 128 Globus Medical shares in Q3 2024, an estimated $8.77K.
  • SWS Partners first reported a position in Globus Medical in Q2 2024 and held it in 1 quarter.
  • SWS Partners's Globus Medical position peaked at $8.77K in Q2 2024.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on SWS Partners's 13F filing for Q3 2024, filed 15 Oct 2024.